← Scroll for more →
CorMedix Inc. (CRMD)
Pharmaceutical Preparations
Latest Price
$5.70
TTM P/E
2.61
Normalized P/E
45.09
TTM Div Yield
--
Fwd Div Yield
--
Book Value
5.87
P/B Ratio
0.97
Valuation metrics
adjust assumptions →EPS: $2.04
Book value / share: $5.11
Formula: √(22.5 × EPS × BVPS)
Graham Number
$15.32
+169% upside
EPS: $2.04
Target P/E: 45×
Formula: EPS × P/E
P/E Fair Value
$91.80
+1512% upside
Institutional Ownership
57.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.32M | $49.0M | 8.14% | +356.5K | 2026-06-30 |
| Deep Track Capital, LP | 6.27M | $49.0M | 8.08% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 3.14M | $24.0M | 4.04% | +5.4K | 2026-06-30 |
| State Street Corp | 2.32M | $18.0M | 2.98% | +125.0K | 2026-06-30 |
| Royce & Associates LP | 2.18M | $17.0M | 2.80% | +288.8K | 2026-06-30 |
| Geode Capital Management, LLC | 1.95M | $15.0M | 2.51% | +130.1K | 2026-06-30 |
| UBS Group AG | 1.88M | $14.0M | 2.42% | +339.7K | 2026-06-30 |
| Oberweis Asset Management Inc/ | 1.32M | $10.0M | 1.70% | +112.8K | 2026-06-30 |
| Alyeska Investment Group, L.P. | 850.0K | $6.0M | 1.09% | -- | 2026-06-30 |
| Marshall Wace, LLP | 779.5K | $6.0M | 1.00% | +276.6K | 2026-06-30 |